Rho Kinase Inhibitors - Role in Glaucoma and Cornea Practice
Downloads
Published
DOI:
https://doi.org/10.56692/upjo.2023110203Keywords:
cornea, glaucoma, Rho kinase, ROCK inhibitorsDimensions Badge
Issue
Section
License
Copyright (c) 2023 Dr. Neha Kumari, Prof. M Vanathi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
© Author, Open Access. This article is licensed under a CC Attribution 4.0 License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/byncsa/4.0/.
The rho-kinase pathway has been implicated in the pathogenesis of various ocular disorders like glaucoma, Fuchs cornealAbstract
dystrophy, diabetic retinopathy, diabetic macular edema, age-related macular degeneration (AMD), ROP. ROCK molecules and
the ROCK pathway regulate multiple physiological functions, such as cell contraction, migration, proliferation, angiogenesis,
chemotaxis, neural protection and vasodilatation, mainly via reorganization of the cytoskeleton. Corneal endothelium increases
endothelial cell proliferation and adhesion and decreases endothelium to mesenchyme transformation. Various studies have
demonstrated their safety and efficacy for ophthalmic use. This review highlights the use of ROCK inhibitors in glaucoma and
corneal diseases.
How to Cite
Downloads
Similar Articles
- Shalini Mohan, Editorial , UP Journal of Ophthalmology: Vol. 9 No. 02 (2021): UP JOURNAL OF OPHTHALMOLOGY
- Kanika Bhardwaj, Tulika Chauhan, Sagarika Patyal, Descemetopexy: A Little More Than Just Providing Support!! A Gist on Descemet Membrane Detachment and Descemetopexy Procedure , UP Journal of Ophthalmology: Vol. 11 No. 02 (2023): UP JOURNAL OF OPHTHALMOLOGY
- Charu Agrawal, Setting Target IOP in Glaucoma , UP Journal of Ophthalmology: Vol. 4 No. 01 (2016): UP JOURNAL OF OPHTHALMOLOGY
- Aditi Jhunjhunwala, Ram Kumar Jaiswal, Pooja Mishra, To Study Ocular Surface Morbidities among Glaucoma Patients on Anti-Glaucoma Drops , UP Journal of Ophthalmology: Vol. 9 No. 03 (2021): UP JOURNAL OF OPHTHALMOLOGY
- Ahmad A, Akhtar N, Abdul Waris, New Frontiers in the Treatment of Normal Tension Glaucoma , UP Journal of Ophthalmology: Vol. 5 No. 01 (2017): UP JOURNAL OF OPHTHALMOLOGY
- Shilpi Arya, Sadaf Abbasi, Sandeep Saxena, Vortex Keratopathy , UP Journal of Ophthalmology: Vol. 13 No. 02 (2025): UP Journal of Ophthalmology
- Siddharth Nakra, Jimmy Mittal, Siddharth Agarwal, Correlation Between The Pressure-to-Cornea Index And Both Structur And Functional Measures Of Primary Open Angle Glaucoma In North Indian Population In And Around Lucknow , UP Journal of Ophthalmology: Vol. 7 No. 01 (2019): UP JOURNAL OF OPHTHALMOLOGY
- Mohan Shalini, Gupta Ramesh Chandra, Khan Perwez, Singh Parul, A Comparative Study of Ocular Blood Flow Parameters in POAG, PACG and Controls in a Tertiary Care Eye Centre , UP Journal of Ophthalmology: Vol. 5 No. 01 (2017): UP JOURNAL OF OPHTHALMOLOGY
- Shalini Mohan, The power of Reading , UP Journal of Ophthalmology: Vol. 8 No. 02 (2020): UP JOURNAL OF OPHTHALMOLOGY
- Ashok Sharma MS,, Rajan Sharma MBBS, Descemet’s Stripping Endothelial Keratoplasty: An Update , UP Journal of Ophthalmology: Vol. 5 No. 01 (2017): UP JOURNAL OF OPHTHALMOLOGY
You may also start an advanced similarity search for this article.
